INTCO MEDICAL(SZ:300677) Xin Lang Cai Jing·2025-09-26 02:50Core Viewpoint - In recent trading, Yingke Medical's stock price has shown significant growth, with a year-to-date increase of 49.08% and a market capitalization of 24.581 billion yuan [1] Group 1: Stock Performance - As of September 26, Yingke Medical's stock price rose by 2.01% to 37.54 yuan per share, with a trading volume of 171 million yuan and a turnover rate of 1.00% [1] - The stock has experienced a 5-day increase of 5.27%, a 20-day increase of 2.21%, and a 60-day increase of 46.64% [1] Group 2: Financial Performance - For the first half of 2025, Yingke Medical reported a revenue of 4.913 billion yuan, representing a year-on-year growth of 8.90%, and a net profit attributable to shareholders of 710 million yuan, up 21.02% year-on-year [2] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for Yingke Medical was 60,000, a decrease of 2.96% from the previous period, with an average of 7,825 circulating shares per person, an increase of 3.07% [2] - The company has distributed a total of 1.903 billion yuan in dividends since its A-share listing, with 245 million yuan distributed in the last three years [3] Group 4: Institutional Holdings - As of June 30, 2025, the second-largest circulating shareholder is Huabao Zhongzheng Medical ETF, holding 15.0151 million shares, an increase of 291,500 shares from the previous period [3] - Other notable institutional shareholders include E Fund Growth ETF and Southern CSI 500 ETF, with varying changes in their holdings [3]